Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Sunday, June 23, 2024 | Back issues
Courthouse News Service Courthouse News Service

Chinese Baby Formula

TRENTON, N.J. - Enzymotec raised $57.4 million at $14 a share in an IPO by misrepresenting its Chinese baby formula business, and the price fell to $9.11 when the truth came out, shareholders claim in a federal class action.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.